FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 292:1310-1313 June 19, 1975 Number 25 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Acetylsalicylic acid was shown both in vivo and in vitro to prevent the platelet lipid peroxidation normally induced by the aggregating agents thrombin and epinephrine, and the sulfhydryl inhibitor N-ethylmaleimide. After aspirin ingestion, there was a significant reduction (p smaller than 0.005) in platelet lipid peroxidation, with a gradual return to base-line values over a 10-day period. With these values, a normal platelet survival curve was constructed with a mean half-life of 4.4 days (range of 2.9 to 5.9 days). These values agree with the standard 51-Cr survivals in three patients with chronic idiopathic thrombocytopenic purpura. Half-lives of 1.0, 2.5, and 4.1 days by lipid peroxide technic compared with 1.9, 2.5, and 3.9 days by the concurrent use of 51-Cr. Thus, the technic may be used to measure platelet survival.

This article has been cited by other articles:

• Brown, S. B., Clarke, M. C. H., Magowan, L., Sanderson, H., Savill, J. (2000). Constitutive Death of Platelets Leading to Scavenger Receptor-mediated Phagocytosis. A CASPASE-INDEPENDENT CELL CLEARANCE PROGRAM. J. Biol. Chem. 275: 5987-5996 [Abstract] [Full Text]  
• Misselwitz, F., Norden, C., Heine, H. (1989). Individually Controlled Aspirin in the Long-Term Treatment of Patients with Chronic Arterial Diseases. ANGIOLOGY 40: 464-471 [Abstract]